The work described herein indicate the need to further explore the expression and activity of CD38—not only within immune populations but also within immunosuppressive cancer cells—to better understand the impact of CD38 on the metabolic profile within tumors and how this, in turn, influences anti-tumor immunity. The gene discussed is CD38; the disease is neoplasm.